Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Warapan Numprasit"'
Autor:
Warapan Numprasit, Supaporn Yangngam, Jaturawitt Prasopsiri, Jean A. Quinn, Joanne Edwards, Chanitra Thuwajit
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundTumoral hypoxia is associated with aggressiveness in many cancers including breast cancer. However, measuring hypoxia is complicated. Carbonic anhydrase IX (CAIX) is a reliable endogenous marker of hypoxia under the control of the master re
Externí odkaz:
https://doaj.org/article/9ad65aca7cb6442ab68024bda5c5c41a
Publikováno v:
Siriraj Medical Journal, Vol 73, Iss 11, Pp 727-731 (2021)
Objective: From previous data, pure flat epithelial atypia (FEA) of the breast demonstrated on core needle biopsy (CNB) was related to malignant upgrading. However, FEA itself is not an independent factor for developing breast cancer; therefore, the
Externí odkaz:
https://doaj.org/article/2e0a8da77ca946cd90813d028c52ab78
Autor:
Warapan Numprasit, Irin Chowchankit, Suebwong Chuthapisith, Malee Warnnissorn, Waraporn Imruetaicharoenchoke
Publikováno v:
Siriraj Medical Journal, Vol 71, Iss 6 (2019)
Objective: The estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 are used to classify invasive breast cancer into various subtypes. In the case of ductal carcinoma in situ (DCIS), however,
Externí odkaz:
https://doaj.org/article/0ac0b5f224c349ac831e779e0756ed9c
Publikováno v:
Siriraj Medical Journal, Vol 71, Iss 6 (2019)
Objective: Age is an important factor for predicting survival, with worse prognosis among young women compared to middle-aged women. Hormone receptor-positive breast cancer is the most commonly reported diagnoses among younger women. This study aimed
Externí odkaz:
https://doaj.org/article/0794009f23584a8497a45fcd921ca240
Autor:
Nuanphan Polchai, Doonyapat Sa-nguanraksa, Thanawat Thumrongtaradol, Warapan Numprasit, Pornchai O-charoenrat, Eng O-charoenrat
Publikováno v:
Cancer Management and Research. 12:5549-5559
Background and Purpose Web-based prognostic calculators have been developed to inform about the use of adjuvant systemic treatments in breast cancer. CancerMath and PREDICT are two examples of web-based prognostic tools that predict patient survival